Comparative analysis of adverse drug reactions to tetracyclines: results of a French national survey and review of the literature
The DOI matches its Crossref record.
Abstract
Background The question of quantitative and qualitative differences between adverse drug reactions (ADRs) to tetracyclines was raised many years ago, especially for minocycline and doxycycline. Objectives To assess and compare ADRs related to tetracyclines according to sales figures in France through a national survey. Methods ADR data were collected from the French Pharmacovigilance Database (FPD), marketing authorization holders (MAH) and the literature. Sales analyses were based on MAH data provided annually to the French Drugs Agency. Results Among the tetracyclines available in France, doxycycline and minocycline are the most frequently used. However, their sales decreased between 1995 and 2007, more sharply for minocycline than doxycycline. According to the FPD, based on MAH data and published reports, minocycline-associated ADRs were more serious and were reported more frequently than for the other tetracyclines. Minocycline and doxycycline ADR patterns differed: gastrointestinal disorders (especially oesophageal lesions) predominated with doxycycline, while intracranial hypertension and hepatic disorders were primarily reported with minocycline. Autoimmune disorders, drug reaction with eosinophilia and systemic symptoms (DRESS) and other hypersensitivity reactions were also more frequent with minocycline. ADRs reported with lymecycline and metacycline were essentially cutaneous and gastrointestinal disorders. Conclusions In the absence of markedly better efficacy agai…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Oral MNC has a relatively high percentage of side effects compared to other oral tetracyclines, 13.6% of the patients might develop side effects [9,10].”
From Formulation and Characterization of PLGA Minocycline Microneedles for Enhanced Skin Deposition and Antibacterial Activity in Acne Treatment (2025) · cites this paper as [9]
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 115
- Gaujoux-Viala, 2010, Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis, Ann Rheum Dis, 69, 1004, 10.1136/ard.2009.127225 · DOI · Paper page
- Doherty, 2008, Evidence-based therapy for cutaneous sarcoidosis, Drugs, 68, 1361, 10.2165/00003495-200868100-00003 · DOI
- Plane, 2010, Prospects for minocycline neuroprotection, Arch Neurol, 67, 1442, 10.1001/archneurol.2010.191 · DOI · Paper page
- Begon, 2004, [Drug hypersensitivity syndrome: DRESS (drug reaction with eosinophilia and systemic symptoms)], Ann Dermatol Venereol, 131, 293, 10.1016/S0151-9638(04)93600-9 · DOI
- Smith, 2005, Safety of doxycycline and minocycline: a systematic review, Clin Ther, 27, 1329, 10.1016/j.clinthera.2005.09.005 · DOI · Paper page
- Grasset, 2003, Cyclines and acne: pay attention to adverse drug reactions! A recent literature review, Rev Med Interne, 24, 305, 10.1016/S0248-8663(02)00017-6 · DOI
- Roberts, 2006, The frequency and distribution of minocycline induced hyperpigmentation in a rheumatoid arthritis population, J Rheumatol, 33, 1254
- Peyrière, 2006, Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?, Br J Dermatol, 155, 422, 10.1111/j.1365-2133.2006.07284.x · DOI · Paper page
- Maubec, 2008, Minocycline-induced DRESS: evidence for accumulation of the culprit drug, Dermatology, 216, 200, 10.1159/000112926 · doi:10.1159/000112926
- Margolis, 2007, Association or lack of association between tetracycline class antibiotics used for acne vulgaris and lupus erythematosus, Br J Dermatol, 157, 540, 10.1111/j.1365-2133.2007.08056.x · DOI · Paper page
- Marzo-Ortega, 2007, Is minocycline therapy in acne associated with antineutrophil cytoplasmic antibody positivity? A cross-sectional study, Br J Dermatol, 156, 1005, 10.1111/j.1365-2133.2007.07828.x · DOI
- Lim, 2003, High-level ultraviolet A photoprotection is needed to prevent doxycycline phototoxicity: lessons learned in East Timor, Br J Dermatol, 149, 213, 10.1046/j.1365-2133.2003.05389.x · DOI
- Heaton, 2007, Association between tetracycline or doxycycline and hepatotoxicity: a population based case-control study, J Clin Pharm Ther, 32, 483, 10.1111/j.1365-2710.2007.00853.x · DOI · Paper page
- El-Hallak, 2008, Chronic minocycline-induced autoimmunity in children, J Pediatr, 153, 314, 10.1016/j.jpeds.2008.03.013 · DOI
- Gait, 2008, Perinuclear antineutrophilic cytoplasmic antibody-positive polyarteritis nodosa secondary to minocycline treatment for acne vulgaris, J Am Acad Dermatol, 58, S123, 10.1016/j.jaad.2007.05.032 · doi:10.1016/j.jaad.2007.05.032
- Ford, 2008, Minocycline hepatitis, Eur J Gastroenterol Hepatol, 20, 796, 10.1097/MEG.0b013e3282f493c5 · DOI
- Ahmed, 2008, Lupus syndrome with neutropenia following minocycline therapy - a case report, Int J Lab Hematol, 30, 543, 10.1111/j.1751-553X.2007.00967.x · doi:10.1111/j.1751-553x.2007.00967.x
- Geddes, 2007, Minocycline-induced lupus in adolescents: clinical implications for physical therapists, J Orthop Sports Phys Ther, 37, 65, 10.2519/jospt.2007.2312 · doi:10.2519/jospt.2007.2312
- Tehrani, 2007, Minocycline-induced cutaneous polyarteritis nodosa, J Clin Rheumatol, 13, 146, 10.1097/RHU.0b013e3180690693 · doi:10.1097/rhu.0b013e3180690693
- Benjamin, 2007, Hyperthyroidism and lupus-like syndrome in an adolescent treated with minocycline for acne vulgaris, Pediatr Dermatol, 24, 246, 10.1111/j.1525-1470.2007.00395.x · DOI
- Leydet, 2006, Lupus induit par la minocycline, Rev Med Interne, 27, 72, 10.1016/j.revmed.2005.09.001 · doi:10.1016/j.revmed.2005.09.001
- Abad, 2006, Additional case of minocycline-induced cutaneous polyarteritis nodosa: comment on the article by Culver et al, Arthritis Rheum, 55, 831, 10.1002/art.22242 · doi:10.1002/art.22242
- Katada, 2006, Minocycline-induced vasculitis fulfilling the criteria of polyarteritis nodosa, Mod Rheumatol, 16, 256, 10.1007/s10165-006-0492-4 · doi:10.1007/s10165-006-0492-4
- Culver, 2005, Case report and review of minocycline-induced cutaneous polyarteritis nodosa, Arthritis Rheum, 53, 468, 10.1002/art.21186 · doi:10.1002/art.21186
- Egger, 2006, Minocycline-induced lupus erythematodes, Praxis (Bern), 95, 1297, 10.1024/0369-8394.95.35.1297 · doi:10.1024/0369-8394.95.35.1297
- Chamberlain, 2006, Minocycline-induced autoimmune hepatitis with subsequent cirrhosis, J Pediatr Gastroenterol Nutr, 42, 232, 10.1097/01.mpg.0000184923.47507.ae · doi:10.1097/01.mpg.0000184923.47507.ae
- Sethi, 2003, ANCA-positive crescentic glomerulonephritis associated with minocycline therapy, Am J Kidney Dis, 42, E27, 10.1016/S0272-6386(03)00671-1 · doi:10.1016/s0272-6386(03)00671-1
- Egiguren, 2007, Patient with autoimmune hepatitis and idiopathic thrombocytopenic purpura after minocycline therapy, Gastroenterol Hepatol, 30, 565, 10.1157/13111686 · DOI
- Fay, 2008, Minocycline-induced hyperpigmentation in rheumatoid arthritis, J Clin Rheumatol, 14, 17, 10.1097/RHU.0b013e31816356d1 · doi:10.1097/rhu.0b013e31816356d1
- Huq, 2008, Spurious bruising in a patient taking warfarin: minocycline-induced skin hyperpigmentation, J Am Geriatr Soc, 56, 1156, 10.1111/j.1532-5415.2008.01696.x · doi:10.1111/j.1532-5415.2008.01696.x
- Tacon, 2008, Drug-induced thyroiditis and papillary carcinoma in a minocycline-pigmented black thyroid gland, Thyroid, 18, 795, 10.1089/thy.2008.0048 · doi:10.1089/thy.2008.0048
- Soung, 2007, Case reports: minocycline-induced hyperpigmentation resolves during oral isotretinoin therapy, J Drugs Dermatol, 6, 1232
- Chatterjee, 2007, Hyperpigmentation associated with minocycline therapy, CMAJ, 176, 321, 10.1503/cmaj.060866 · doi:10.1503/cmaj.060866
- Madan, 2007, Minocycline-induced pigmentation of pre-existing capillaritis, Br J Dermatol, 156, 590, 10.1111/j.1365-2133.2007.07680.x · doi:10.1111/j.1365-2133.2007.07680.x
- Carman, 2006, Images in vascular medicine. Drug-related skin and atherosclerotic plaque pigmentation, Vasc Med, 11, 276, 10.1177/1358863x06073459 · doi:10.1177/1358863x06073459
- Bruins, 2007, Papillary thyroid carcinoma in a patient with sarcoidosis treated with minocycline, Neth J Med, 65, 185
- Ban, 2007, Nail discoloration occurring after 8 weeks of minocycline therapy, J Dermatol, 34, 699, 10.1111/j.1346-8138.2007.00362.x · doi:10.1111/j.1346-8138.2007.00362.x
- Bowen, 2007, The histopathology of subcutaneous minocycline pigmentation, J Am Acad Dermatol, 57, 836, 10.1016/j.jaad.2007.04.028 · doi:10.1016/j.jaad.2007.04.028
- Gerson, 2006, Black pigmentation of atherosclerotic plaques associated with chronic minocycline therapy, Cardiovasc Pathol, 15, 168, 10.1016/j.carpath.2005.11.002 · doi:10.1016/j.carpath.2005.11.002
- Rahman, 2005, Minocycline hyperpigmentation isolated to the subcutaneous fat, J Cutan Pathol, 32, 516, 10.1111/j.0303-6987.2005.00369.x · doi:10.1111/j.0303-6987.2005.00369.x
- Suwannarat, 2004, Minocycline-induced hyperpigmentation masquerading as alkaptonuria in individuals with joint pain, Arthritis Rheum, 50, 3698, 10.1002/art.20606 · doi:10.1002/art.20606
- Alkhatib, 2006, The tarnished tongue, Am J Med, 119, 832, 10.1016/j.amjmed.2006.07.031 · doi:10.1016/j.amjmed.2006.07.031
- Kalia, 2006, Dermacase. Minocycline-induced pigmentation, Can Fam Physician, 52, 595
- Treister, 2004, Oral mucosal pigmentation secondary to minocycline therapy: report of two cases and a review of the literature, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 97, 718, 10.1016/j.tripleo.2003.11.006 · doi:10.1016/j.tripleo.2003.11.006
- Anonymous, 2004, Pathologic quiz case: tumor in pigmented thyroid gland in a young man. Papillary thyroid carcinoma in a minocycline-induced, diffusely pigmented thyroid gland, Arch Pathol Lab Med, 128, 355, 10.5858/2004-128-355-PQCTIP · doi:10.5858/2004-128-355-pqctip
- Pantanowitz, 2003, Black thyroid, Ear Nose Throat J, 82, 676, 10.1177/014556130308200908 · doi:10.1177/014556130308200908
- Dodiuk-Gad, 2006, Minocycline-induced cutaneous hyperpigmentation: confocal laser scanning microscope analysis, J Eur Acad Dermatol Venereol, 20, 435, 10.1111/j.1468-3083.2006.01436.x · DOI
- Hepburn, 2005, Minocycline-induced black bone disease, Orthopedics, 28, 501, 10.3928/0147-7447-20050501-20 · doi:10.3928/0147-7447-20050501-20
- Patterson, 2004, Hyperpigmented scar due to minocycline therapy, Cutis, 74, 293
- Pandit, 2004, Black pigmentation of bone due to long-term minocycline use, Surgeon, 2, 236, 10.1016/S1479-666X(04)80008-8 · doi:10.1016/s1479-666x(04)80008-8
- LaPorta, 2005, Minocycline-associated intra-oral soft-tissue pigmentation: clinicopathologic correlations and review, J Clin Periodontol, 32, 119, 10.1111/j.1600-051X.2005.00646.x · DOI
- Damm, 2004, Blue palate and alveolar ridge, Gen Dent, 52, 554
- Alster, 2004, Minocycline-induced hyperpigmentation treated with a 755-nm Q-switched alexandrite laser, Dermatol Surg, 30, 1201, 10.1111/j.1524-4725.2004.30372.x · doi:10.1111/j.1524-4725.2004.30372.x
- Herbers, 2004, Bluish-grey pigmentation of fingernails, gingiva, teeth and peri-oral region. Minocycline, Neth J Med, 62, 58
- Hawfield, 2004, Trauma-induced cutaneous pigmentation from tetracycline: a case report, Pediatr Dermatol, 21, 164, 10.1111/j.0736-8046.2004.21216.x · doi:10.1111/j.0736-8046.2004.21216.x
- Mouton, 2004, A new type of minocycline-induced cutaneous hyperpigmentation, Clin Exp Dermatol, 29, 8, 10.1111/j.1365-2230.2004.01421.x · doi:10.1111/j.1365-2230.2004.01421.x
- McCleskey, 2004, Minocycline-induced blue-green discoloration of bone. A case report, J Bone Joint Surg Am, 86, 146, 10.2106/00004623-200401000-00023 · doi:10.2106/00004623-200401000-00023
- Shimizu, 2008, Case of acute eosinophilic pneumonia probably induced by minocycline, Nihon Kokyuki Gakkai Zasshi, 46, 136
- Brown, 2009, Minocycline-induced drug hypersensitivity syndrome followed by multiple autoimmune sequelae, Arch Dermatol, 145, 63, 10.1001/archdermatol.2008.521 · DOI
- Yamasawa, 2008, Case of minocycline-induced acute eosinophilic pneumonia accompanied by marked neutrophilia in the peripheral blood, Nihon Kokyuki Gakkai Zasshi, 46, 820
- Losanoff, 2007, Minocycline toxicity requiring liver transplant, Dig Dis Sci, 52, 3242, 10.1007/s10620-006-9550-1 · doi:10.1007/s10620-006-9550-1
- Ono, 2007, Minocycline-induced acute eosinophilic pneumonia: controversial results of lymphocyte stimulation test and re-challenge test, Intern Med, 46, 593, 10.2169/internalmedicine.46.6235 · doi:10.2169/internalmedicine.46.6235
- Favrolt, 2007, [Severe drug rash with eosinophilia and systemic symptoms after treatment with minocycline], Rev Mal Respir, 24, 892, 10.1016/S0761-8425(07)91393-5 · doi:10.1016/s0761-8425(07)91393-5
- Arai, 2007, [Case of minocycline-induced pneumonitis with bilateral pleural effusion], Arerugi, 56, 1293
- Muller, 2003, Drug hypersensitivity syndrome in a West-Indian population, Eur J Dermatol, 13, 478
- Dukic, 2004, Papulose lymphomatoïde atypique à grandes cellules supposée déclenchée par la minocycline, Rev Med Interne, 25, 397, 10.1016/j.revmed.2004.02.010 · doi:10.1016/j.revmed.2004.02.010
- Rikken, 2004, Interstitial pneumonia and hepatitis caused by minocycline, Neth J Med, 62, 62
- Hammerer, 2004, Alvéolite neutrophilique due à la minocycline?, Rev Pneumol Clin, 60, 46, 10.1016/S0761-8417(04)72083-0 · doi:10.1016/s0761-8417(04)72083-0
- Real Martinez, 2003, [Acute hepatitis and minocycline], Rev Esp Enferm Dig, 95, 741
- Bamberg, 2003, [Cutaneous xanthomas associated with minocycline-induced cholestatic jaundice], Hautarzt, 54, 864, 10.1007/s00105-003-0525-2 · doi:10.1007/s00105-003-0525-2
- Tsuruta, 2006, Drug hypersensitivity syndrome caused by minocycline, J Cutan Med Surg, 10, 131, 10.2310/7750.2006.00019 · doi:10.2310/7750.2006.00019
- Trivin, 2005, [Minocycline-induced drug hypersensitivity syndrome with hepatic disease], Therapie, 60, 590, 10.2515/therapie:2005084 · doi:10.2515/therapie:2005084
- Carlson, 2006, Adverse antibiotic-induced eruptions associated with Epstein-Barr virus infection and showing Kikuchi-Fujimoto disease-like histology, Am J Dermatopathol, 28, 48, 10.1097/01.dad.0000164604.56650.26 · DOI
- Lee, 2005, Cardiogenic shock and peripheral eosinophilia in a young woman, Ann Allergy Asthma Immunol, 95, 229, 10.1016/S1081-1206(10)61218-5 · DOI
- Hidalgo Correas, 2005, Minocycline-induced pleurocarditis and eosinophilic pneumonia: a propos of a case, Farm Hosp, 29, 145, 10.1016/S1130-6343(05)73652-7 · doi:10.1016/s1130-6343(05)73652-7
- Kesler, 2004, The outcome of pseudotumor cerebri induced by tetracycline therapy, Acta Neurol Scand, 110, 408, 10.1111/j.1600-0404.2004.00327.x · doi:10.1111/j.1600-0404.2004.00327.x
- Fukui, 2004, [Case of drug-induced pneumonia followed by sequential bronchoalveolar lavage], Nihon Kokyuki Gakkai Zasshi, 42, 743
- Grim, 2003, Late-onset drug fever associated with minocycline: case report and review of the literature, Pharmacotherapy, 23, 1659, 10.1592/phco.23.15.1659.31966 · DOI
- Heidrich, 2004, [Stomatitis, glossitis, and esophagitis in a patient treated with minocycline], Med Klin (Munich), 99, 396, 10.1007/s00063-004-1058-x · doi:10.1007/s00063-004-1058-x
- Cohen, 2004, Medication-associated depersonalization symptoms: report of transient depersonalization symptoms induced by minocycline, South Med J, 97, 70, 10.1097/01.SMJ.0000083857.98870.98 · DOI
- Ayaslioglu, 2005, Doxycycline-induced staining of permanent adult dentition, Aust Dent J, 50, 273, 10.1111/j.1834-7819.2005.tb00373.x · doi:10.1111/j.1834-7819.2005.tb00373.x
- Miller, 2006, Black thyroid resulting from short-term doxycycline use: case report, review of the literature, and discussion of implications, Head Neck, 28, 373, 10.1002/hed.20385 · doi:10.1002/hed.20385
- Akcam, 2005, Nail discoloration induced by doxycycline, Pediatr Infect Dis J, 9, 845, 10.1097/01.inf.0000177283.71692.56 · DOI
- Nelson, 2006, Doxycycline-induced staining of adult teeth: the first reported case, Arch Dermatol, 142, 1081, 10.1001/archderm.142.8.1081 · doi:10.1001/archderm.142.8.1081
- Volovitz, 2007, Absence of tooth staining with doxycycline treatment in young children, Clin Pediatr, 46, 121, 10.1177/0009922806290026 · DOI · Paper page
- Heveling, 2007, Doxycycline-induced amnesia: a case report, Eur J Clin Pharmacol, 63, 95, 10.1007/s00228-006-0221-0 · doi:10.1007/s00228-006-0221-0
- Segelnick, 2008, Recognizing doxycycline-induced esophageal ulcers in dental practice: a case report and review, J Am Dent Assoc, 139, 581, 10.14219/jada.archive.2008.0218 · doi:10.14219/jada.archive.2008.0218
- Passalidou, 2006, Un cas d’ulcère oesophagien secondaire à la prise de doxycycline, Arch Pédiatr, 13, 90, 10.1016/j.arcped.2005.10.014 · doi:10.1016/j.arcped.2005.10.014
- Grgurevic, 2005, [Doxycycline induced esophageal ulcers: report of two cases and review of the literature], Lijec Vjesn, 127, 285
- Alonso Fernandez, 2005, [Oesophageal ulcer and doxycycline], Aten Primaria, 36, 224
- Valean, 2005, Pill esophagitis, Rom J Gastroenterol, 14, 159
- Pociello Alminana, 2005, Doxycycline-induced esophagitis: report of two cases, Ann Pediatr, 62, 171
- Kadayifci, 2004, Doxycycline-induced pill esophagitis, Dis Esophagus, 17, 168, 10.1111/j.1442-2050.2004.00384.x · doi:10.1111/j.1442-2050.2004.00384.x
- Gencosmanoglu, 2004, Mid-esophageal ulceration and candidiasis-associated distal esophagitis as two distinct clinical patterns of tetracycline or doxycycline-induced esophageal injury, J Clin Gastroenterol, 38, 484, 10.1097/01.mcg.0000129058.69524.90 · DOI
- Rabar, 2004, Doxycycline-induced photo-onycholysis, J Travel Med, 11, 386, 10.2310/7060.2004.19210 · DOI
- Carroll, 2003, Doxycycline-induced photo-onycholysis, J Drugs Dermatol, 2, 662
- Passier, 2004, Photo-onycholysis associated with the use of doxycycline, BMJ, 329, 265, 10.1136/bmj.329.7460.265 · DOI
- Habif, 2006, Doxycycline-induced phototoxicity, N Engl J Med, 355, 182, 10.1056/NEJMicm050829 · doi:10.1056/nejmicm050829
- Ghozzi, 2008, [Benign intracranial hypertension induced by doxycycline], Tunis Med, 86, 510
- Tabibian, 2009, Doxycycline-induced pseudotumor cerebri, South Med J, 102, 310, 10.1097/SMJ.0b013e31818f98f0 · doi:10.1097/smj.0b013e31818f98f0
- Chan, 2005, Doxycycline and intracranial hypertension, Neurology, 64, 765, 10.1212/WNL.64.4.765-a · doi:10.1212/wnl.64.4.765-a
- Friedman, 2004, Doxycycline and intracranial hypertension, Neurology, 62, 2297, 10.1212/WNL.62.12.2297 · doi:10.1212/wnl.62.12.2297
- Robles, 2008, Severe drug hypersensitivity reaction in a young woman treated with doxycycline, Dermatology, 217, 23, 10.1159/000119753 · DOI
- Sabatine, 2007, Case records of the Massachusetts General Hospital. Case 36-2007. A 31-year-old woman with rash, fever, and hypotension, N Engl J Med, 357, 2167, 10.1056/NEJMcpc079030 · DOI
- Gul, 2008, Doxycycline-induced fixed drug eruption, J Dermatolog Treat, 19, 126, 10.1080/09546630701759561 · doi:10.1080/09546630701759561
- Jamet, 2008, Doxycycline-induced Sweet’s syndrome, Eur J Dermatol, 18, 595
- Izzedine, 2004, Doxycycline, gastrointestinal bleeding, and thrombotic microangiopathy, Am J Hematol, 77, 319, 10.1002/ajh.20174 · doi:10.1002/ajh.20174
- Knox-Macaulay, 2004, Acute thrombotic thrombocytopenic purpura following doxycycline treatment of Chlamydia pneumoniae infection in a patient with dermatomyositis, Clin Lab Haematol, 26, 147, 10.1111/j.1365-2257.2004.00594.x · doi:10.1111/j.1365-2257.2004.00594.x
- Selimoglu, 2003, Autoimmune hepatitis triggered by Brucella infection or doxycycline or both, Int J Clin Pract, 57, 639, 10.1111/j.1742-1241.2003.tb10577.x · doi:10.1111/j.1742-1241.2003.tb10577.x
- Ramsakal, 2007, Images in clinical medicine. Lingua villosa nigra, N Engl J Med, 357, 2388, 10.1056/NEJMicm065655 · doi:10.1056/nejmicm065655
- Cac, 2007, Stevens-Johnson syndrome induced by doxycycline, Cutis, 79, 119
- Lehembre, 2007, Stevens-Johnson syndrome due to lymecycline, Ann Dermatol Venereol, 134, 461, 10.1016/S0151-9638(07)89214-3 · doi:10.1016/s0151-9638(07)89214-3
- AFSSAPS, 2008, Recommendations of good clinical practice on the treatment of acne, Ann Dermatol Venereol, 135, S137
- Dréno, 2004, European recommendations on the use of oral antibiotics for acne, Eur J Dermatol, 14, 391
- Ochsendorf, 2010, Minocycline in acne vulgaris: benefits and risks, Am J Clin Dermatol, 11, 327, 10.2165/11319280-000000000-00000 · DOI
Cited by
Guidelines of care for the management of acne vulgaris
Zaenglein, A. L., Pathy, A. L., Schlosser, B. J., Alikhan, A., Baldwin, H. E., Berson, D. S., Bowe, W. P., Graber, E. M., Harper, J. C., Kang, S., et al. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.12.037 · Cited by 1,597
Severe cutaneous adverse reactions to drugs
Duong, T. A., Valeyrie-Allanore, L., Wolkenstein, P., & Chosidow, O. (2017) · The Lancet · doi:10.1016/s0140-6736(16)30378-6 · Cited by 445
Self-citationSide effects of common acne treatments
Tripathi, S. V., Gustafson, C. J., Huang, K. E., & Feldman, S. R. (2013) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2013.740456 · Cited by 70
Abu Ershaid, J. M., Abudoleh, S. M., Lafi, D. N., & Dahshan, N. A. (2025) · Polymers · doi:10.3390/polym17212912 · Cited by 5
Metadata
- Authors
- Lebrun-Vignes, B., Kreft-Jais, C., Castot, A., Chosidow, O., & the French Network of Regional Centers of Pharmacovigilance
- Venue
- British Journal of Dermatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-05-25
- Volume
- 166
- Issue
- 6
- Pages
- 1333-1341
- ISSN
- 0007-0963
- Cited by
- 61
- References
- 0
- Language
- en
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 1194 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.